stella
beta
Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer — Stella
Recruiting
Back to Ovarian Cancer Recurrent trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Obstetrics and Gynecology Hospital of Fudan University, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov